Revision as of 11:47, 3 September 2011 editBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot← Previous edit | Latest revision as of 23:14, 29 January 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers174,387 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper | ||
(19 intermediate revisions by 16 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} | |||
{{unreferenced|date=June 2011}} | |||
{{Drugbox | {{Drugbox | ||
| Verifiedfields = changed | |||
⚫ | | verifiedrevid = |
||
| Watchedfields = changed | |||
⚫ | | verifiedrevid = 444222259 | ||
| IUPAC_name = 6--3,3-dimethyl-7-oxo-4-thia-1-azabicycloheptane-2-carboxylic acid | | IUPAC_name = 6--3,3-dimethyl-7-oxo-4-thia-1-azabicycloheptane-2-carboxylic acid | ||
| image = Azidocillin. |
| image = Azidocillin.svg | ||
<!--Clinical data--> | <!--Clinical data--> | ||
Line 15: | Line 17: | ||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| legal_status = | | legal_status = | ||
| routes_of_administration = | | routes_of_administration = Oral, ], ] | ||
<!--Pharmacokinetic data--> | <!--Pharmacokinetic data--> | ||
| bioavailability = |
| bioavailability = 57–64% | ||
| protein_bound = |
| protein_bound = | ||
| metabolism = |
| metabolism = | ||
| elimination_half-life = | | elimination_half-life = 0.6-1.1 hrs | ||
| excretion = | | excretion = 37–50% active substance in urine | ||
<!--Identifiers--> | <!--Identifiers--> | ||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 17243-38-8 | | CAS_number = 17243-38-8 | ||
| ATC_prefix = J01 | | ATC_prefix = J01 | ||
Line 31: | Line 34: | ||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | ||
| DrugBank = DB08795 | | DrugBank = DB08795 | ||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | |||
| ChEMBL = 2105907 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ||
| ChemSpiderID = 16735689 | | ChemSpiderID = 16735689 | ||
Line 41: | Line 46: | ||
<!--Chemical data--> | <!--Chemical data--> | ||
| C=16 | H=17 | N=5 | O=4 | S=1 |
| C=16 | H=17 | N=5 | O=4 | S=1 | ||
| molecular_weight = 375.40228 | |||
| smiles = O=C(O)2N3C(=O)(NC(=O)(\N==)c1ccccc1)3SC2(C)C | | smiles = O=C(O)2N3C(=O)(NC(=O)(\N==)c1ccccc1)3SC2(C)C | ||
| InChI = 1/C16H17N5O4S/c1-16(2)11(15(24)25)21-13(23)10(14(21)26-16)18-12(22)9(19-20-17)8-6-4-3-5-7-8/h3-7,9-11,14H,1-2H3,(H,18,22)(H,24,25)/t9-,10-,11+,14-/m1/s1 | |||
| InChIKey = ODFHGIPNGIAMDK-NJBDSQKTBL | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | ||
| StdInChI = 1S/C16H17N5O4S/c1-16(2)11(15(24)25)21-13(23)10(14(21)26-16)18-12(22)9(19-20-17)8-6-4-3-5-7-8/h3-7,9-11,14H,1-2H3,(H,18,22)(H,24,25)/t9-,10-,11+,14-/m1/s1 | | StdInChI = 1S/C16H17N5O4S/c1-16(2)11(15(24)25)21-13(23)10(14(21)26-16)18-12(22)9(19-20-17)8-6-4-3-5-7-8/h3-7,9-11,14H,1-2H3,(H,18,22)(H,24,25)/t9-,10-,11+,14-/m1/s1 | ||
Line 51: | Line 53: | ||
| StdInChIKey = ODFHGIPNGIAMDK-NJBDSQKTSA-N | | StdInChIKey = ODFHGIPNGIAMDK-NJBDSQKTSA-N | ||
}} | }} | ||
'''Azidocillin''' is a type of ].<ref>{{cite journal | vauthors = Axelsson A, Jensen C, Melin O, Singer F, von Sydow C | title = Treatment of acute maxillary sinusitis. V. Amoxicillin azidocillin, phenylpropanolamine and pivampicillin | journal = Acta Oto-Laryngologica | volume = 91 | issue = 3–4 | pages = 313–8 | year = 1981 | pmid = 6894819 | doi = 10.3109/00016488109138513 }}</ref><ref>{{cite journal | vauthors = Bergan T, Sørensen G | title = Pharmacokinetics of azidocillin in healthy adults | journal = Arzneimittel-Forschung | volume = 30 | issue = 12 | pages = 2185–91 | year = 1980 | pmid = 6894241 }}</ref> | |||
'''Azidocillin''' is a type of ]. | |||
== References == | |||
{{reflist}} | |||
{{Cell wall disruptive antibiotics}} | {{Cell wall disruptive antibiotics}} | ||
⚫ | ] | ||
] | |||
{{antibiotic-stub}} | |||
] | |||
⚫ | ] |
Latest revision as of 23:14, 29 January 2023
Chemical compound Pharmaceutical compoundClinical data | |
---|---|
Routes of administration | Oral, IV, IM |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 57–64% |
Elimination half-life | 0.6-1.1 hrs |
Excretion | 37–50% active substance in urine |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.037.510 |
Chemical and physical data | |
Formula | C16H17N5O4S |
Molar mass | 375.40 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Azidocillin is a type of penicillin.
References
- Axelsson A, Jensen C, Melin O, Singer F, von Sydow C (1981). "Treatment of acute maxillary sinusitis. V. Amoxicillin azidocillin, phenylpropanolamine and pivampicillin". Acta Oto-Laryngologica. 91 (3–4): 313–8. doi:10.3109/00016488109138513. PMID 6894819.
- Bergan T, Sørensen G (1980). "Pharmacokinetics of azidocillin in healthy adults". Arzneimittel-Forschung. 30 (12): 2185–91. PMID 6894241.